Skip to main content
. 2024 Feb 12;9(2):102236. doi: 10.1016/j.esmoop.2024.102236

Table 2.

Multivariate analysis of factors associated with poor body image, sexual inactivity, poor sexual functioning, and poor sexual enjoyment

Exposable variable Body image
Sexual functioning
Sexually inactive
Sexual enjoyment
OR 95% CI P value OR 95% CI P value OR 95% CI P value OR 95% CI P value
Age, <40 years versus >65 years 1.08 0.86-1.36 0.460 0.17 0.12-0.23 <0.0001 0.18 0.13-0.24 <0.0001 0.49 0.34-0.71 0.001
Age, 40-49 years versus >65 years 1.12 0.95-1.31 0.152 0.22 0.18-0.27 <0.0001 0.22 0.18-0.27 <0.0001 0.81 0.60-1.08 0.160
Age, 50-64 years versus >65 years 1.02 0.90-1.16 0.658 0.49 0.43-0.57 <0.0001 0.49 0.43-0.57 <0.0001 0.85 0.66-1.11 0.260
Marital status, partnered versus not partnered 0.95 0.83-1.09 0.519 2.22 1.89-2.60 <0.0001 2.29 1.95-2.68 <0.0001 0.74 0.51-1.07 0.112
Education, high versus primary school 1.13 1.01-1.26 0.027 1.02 0.89-1.16 0.715 1.02 0.90-1.16 0.673 0.95 0.80-1.13 0.578
Education, college versus primary school 0.73 0.62-0.86 0.001 1.10 0.91-1.33 0.300 1.14 0.95-1.38 0.149 1.58 1.09-2.30 0.015
Monthly income, ≥1500-<3000 euros versus <1500 euros 1.10 0.98-1.23 0.076 0.86 0.75-0.98 0.031 0.84 0.73-0.96 0.011 0.85 0.72-1.01 0.079
Monthly income, ≥3000 euros versus <1500 euros 1.04 0.88-1.22 0.626 1.20 0.99-1.45 0.056 1.22 1.01-1.48 0.031 1.09 0.76-1.54 0.627
Comorbidity score, ≥1 versus 0 1.00 0.88-1.14 0.914 1.04 0.90-1.21 0.525 1.03 0.89-1.19 0.649 0.95 0.76-1.18 0.668
Smoke behavior, current versus never 1.19 1.05-1.34 0.003 0.97 0.84-1.13 0.779 0.96 0.83-1.10 0.601 0.87 0.72-1.06 0.180
Smoke behavior, former versus never 1.33 1.16-1.53 <0.0001 1.08 0.92-1.27 0.322 1.09 0.93-1.29 0.256 0.81 0.65-1.02 0.075
Daily alcohol consumption, yes versus no 1.00 0.87-1.15 0.923 0.99 0.84-1.17 0.940 0.99 0.84-1.17 0.941 0.92 0.73-1.16 0.506
BMI, ≥25 kg/m2 versus <25 kg/m2 1.24 1.12-1.37 <0.0001 1.13 1.01-1.28 0.032 1.12 0.99-1.26 0.054 0.96 0.81-1.13 0.627
Level of physical activity, sufficiently versus insufficiently active 1.04 0.94-1.14 0.405 0.99 0.88-1.11 0.869 1.01 0.90-1.14 0.740 1.04 0.89-1.22 0.585
Chemotherapy, yes versus no 1.88 1.68-2.10 <0.0001 1.19 1.03-1.36 0.013 1.16 1.01-1.33 0.029 0.99 0.81-1.20 0.928
Endocrine therapy, yes versus no 1.15 1.01-1.31 0.026 1.19 1.02-1.39 0.023 1.17 1.01-1.37 0.032 1.23 1.00-1.53 0.046
Use of ovarian function suppression, yes versus no 0.98 0.70-1.37 0.912 1.33 0.91-1.93 0.128 1.37 0.95-1.98 0.091 1.03 0.63-1.67 0.885
Anti-HER2 therapy, yes versus no 0.99 0.84-1.15 0.913 1.10 0.91-1.34 0.299 1.14 0.94-1.38 0.181 1.28 1.02-1.62 0.031
Radiotherapy, yes versus no 0.79 0.64-0.97 0.029 0.92 0.73-1.17 0.533 0.93 0.74-1.17 0.546 1.01 0.72-1.42 0.944
Axillary surgery, dissection versus sentinel/no 1.08 0.96-1.21 0.171 1.00 0.87-1.15 0.977 1.02 0.89-1.17 0.751 1.09 0.90-1.32 0.332
Breast surgery, mastectomy versus conservative 1.99 1.74-2.28 <0.0001 1.05 0.89-1.24 0.502 1.04 0.88-1.22 0.629 1.09 0.88-1.35 0.406
Anxiety (at T1), doubtful/case versus noncase 1.80 1.62-1.99 <0.0001 0.91 0.80-1.03 0.152 0.91 0.80-1.04 0.181 0.99 0.84-1.17 0.959
Depression (at T1), doubtful/case versus noncase 2.00 1.72-2.34 <0.0001 1.66 1.40-1.97 <0.0001 1.69 1.43-2.00 <0.0001 1.94 1.50-2.51 <0.0001
Vaginal dryness (at T1), yes versus no 1.16 1.05-1.29 0.002 0.73 0.64-0.82 <0.0001 0.73 0.64-0.83 <0.0001 1.82 1.55-2.14 <0.0001
Hot flashes (at T1), yes versus no 1.22 1.10-1.35 <0.0001 1.02 0.90-1.15 0.694 1.01 0.89-1.14 0.819 1.20 1.01-1.43 0.037
Poor role functioning (at T1), yes versus no 0.89 0.75-1.06 0.204 1.04 0.85-1.27 0.700 1.05 0.86-1.29 0.578 0.97 0.73-1.29 0.857
Poor social functioning (at T1), yes versus no 1.65 1.39-1.97 <0.0001 1.22 0.98-1.50 0.063 1.17 0.95-1.45 0.117 1.24 0.92-1.66 0.147
Severe fatigue (at T1), yes versus no 1.48 1.31-1.67 <0.0001 1.07 0.92-1.25 0.318 1.11 0.95-1.28 0.163 1.21 0.99-1.48 0.053
Severe pain (at T1), yes versus no 1.31 1.14-1.50 <0.0001 1.13 0.96-1.34 0.123 1.13 0.96-1.33 0.138 1.12 0.90-1.40 0.302
Severe insomnia (at T1), yes versus no 1.16 1.04-1.29 0.005 1.13 1.00-1.29 0.050 1.13 1.00-1.29 0.048 1.17 0.98-1.40 0.081
Consultation with a gynecologist (at T1), yes versus no 0.99 0.89-1.10 0.919 0.74 0.65-0.84 <0.0001 0.75 0.66-0.86 <0.0001 0.81 0.69-0.95 0.011
Consultation with a psychiatrist/psychologist (at T1), yes versus no 1.11 0.97-1.27 0.099 1.11 0.94-1.31 0.205 1.10 0.94-1.30 0.214 0.96 0.78-1.17 0.698
Sexual concern (at T0), yes versus no 3.48 3.11-3.89 <0.0001 9.94 8.84-11.1 <0.0001 9.75 8.67-10.9 <0.0001 3.96 3.34-4.69 <0.0001

BMI, body mass index; CI, confidence interval; HER2, human epidermal growth factor receptor 2; OR, odds ratio; T0, at the moment of diagnosis; T1, year 1 after diagnosis.